South Africa: 'Brilliant 011' Vaccine Trial Begins, 20 Participants Enrolled in Trial
South Africa has launched its first human HIV vaccine trial, marking a major milestone in the global fight against HIV/AIDS. The ‘Brilliant 011’ trial begins as the country continues to battle the world’s largest HIV epidemic, raising hopes for a breakthrough in prevention.
Trending Videos